All Stories

  1. 3D printed system using ex vivo porcine eye globes to investigate intracorneal absorption of dexpanthenol from contact lens care solution and eye drops
  2. Comparing the efficacy of nanocarriers for cutaneous and follicular delivery of poorly water-soluble molecules: A case study with ciclosporin A
  3. In Vitro Evaluation of Topical Follicular Delivery of Minoxidil and Latanoprost Co-Entrapped in Lipid Nanocarriers
  4. Bioanalytical UHPLC–MS/MS Method for Quantification of Terbinafine in Ungual Delivery Studies
  5. Iontophoretic delivery of caspofungin acetate to the cornea and sclera and its intracorneal biodistribution
  6. Cutaneous delivery and biodistribution of a lipophilic natural product – bakuchiol: Comparing nanocarrier performance
  7. Trends and Commonalities of Approved and Late Clinical-Phase RNA Therapeutics
  8. Development of an ex vivo human skin model and evaluation of biological responses to subcutaneously injected hyaluronic acid formulations
  9. Non-Invasive Delivery of Negatively Charged Nanobodies by Anodal Iontophoresis: When Electroosmosis Dominates Electromigration
  10. Cutaneous Delivery and Biodistribution of Cannabidiol in Human Skin after Topical Application of Colloidal Formulations
  11. Clinical Perspectives on the Injectability of Cross-Linked Hyaluronic Acid Dermal Fillers: A Standardized Methodology for Commercial Product Benchmarking with Inter-Injector Assessments
  12. Enhancing Oral Delivery of Biologics: A Non-Competitive and Cross-Reactive Anti-Leptin Receptor Nanofitin Demonstrates a Gut-Crossing Capacity in an Ex Vivo Porcine Intestinal Model
  13. Development of an ex vivo porcine skin model for the preclinical evaluation of subcutaneously injected biomacromolecules
  14. Enhanced topical paromomycin delivery for cutaneous leishmaniasis treatment: Passive and iontophoretic approaches
  15. Polymeric micelles for cutaneous delivery of the hedgehog pathway inhibitor TAK-441: Formulation development and cutaneous biodistribution in porcine and human skin
  16. Injectable Hyaluronan-Based Thermoresponsive Hydrogels for Dermatological Applications
  17. Influence of Molecular Structure and Physicochemical Properties of Immunosuppressive Drugs on Micelle Formulation Characteristics and Cutaneous Delivery
  18. Non-Invasive Iontophoretic Delivery of Cytochrome c to the Posterior Segment and Determination of Its Ocular Biodistribution
  19. Simultaneous Delivery of Econazole, Terbinafine and Amorolfine with Improved Cutaneous Bioavailability: A Novel Micelle-Based Antifungal “Tri-Therapy”
  20. Effect of mRNA Delivery Modality and Formulation on Cutaneous mRNA Distribution and Downstream eGFP Expression
  21. Controlled simultaneous iontophoresis of buflomedil hydrochloride and dexamethasone sodium phosphate to the mucosa for oral submucous fibrosis
  22. DESI-MS imaging to visualize spatial distribution of xenobiotics and endogenous lipids in the skin
  23. Current profile controlled transdermal delivery of pramipexole from an iontophoretic patch system in vitro and in vivo
  24. Using Porcine Jejunum Ex Vivo to Study Absorption and Biotransformation of Natural Products in Plant Extracts: Pueraria lobata as a Case Study
  25. Microemulsion-based gel for the transdermal delivery of rasagiline mesylate: In vitro and in vivo assessment for Parkinson’s therapy
  26. Polymeric micelle mediated follicular delivery of spironolactone: Targeting the mineralocorticoid receptor to prevent glucocorticoid-induced activation and delayed cutaneous wound healing
  27. Polymeric micelle formulations for the cutaneous delivery of sirolimus: A new approach for the treatment of facial angiofibromas in tuberous sclerosis complex
  28. The influence of skin barrier impairment on the iontophoretic transport of low and high molecular weight permeants
  29. Effect of continuous and multi-phasic current profiles on the iontophoretic transport of pramipexole, rasagiline and huperzine A: Depicting temporal variation and biodistribution in the skin
  30. Co-administration of zinc phthalocyanine and quercetin via hybrid nanoparticles for augmented photodynamic therapy
  31. Iontosomes: Electroresponsive Liposomes for Topical Iontophoretic Delivery of Chemotherapeutics to the Buccal Mucosa
  32. Using protease inhibitors to improve protein stability in the presence of skin: A case study on the stability of insulin like growth factor 1
  33. Withdrawal notice to ‘WITHDRAWN: Specific protein-protein interactions limit the cutaneous iontophoretic transport of interferon beta-1B and a poly-ARG interferon beta-1B analogue’ [International Journal of Pharmaceutics 589 (2020) 119913]
  34. Specific protein-protein interactions limit the cutaneous iontophoretic transport of interferon beta-1b and a poly-Arg interferon beta-1b analogue
  35. Using Ex Vivo Porcine Jejunum to Identify Membrane Transporter Substrates: A Screening Tool for Early—Stage Drug Development
  36. Specific protein-protein interactions limit the cutaneous iontophoretic transport of interferon beta-1B and a poly-ARG interferon beta-1B analogue
  37. Tissue Levels of Flurbiprofen in the Rat Plantar Heel after Short-Duration Topical Iontophoresis are Sufficient to Induce Pharmacodynamic Responses to Local Pain Stimuli
  38. Targeted cutaneous delivery of etanercept using Er:YAG fractional laser ablation
  39. Non-invasive targeted iontophoretic delivery of cetuximab to skin
  40. Ocular Biodistribution of Spironolactone after a Single Intravitreal Injection of a Biodegradable Sustained-Release Polymer in Rats
  41. Cutaneous Biodistribution: A High-Resolution Methodology to Assess Bioequivalence in Topical Skin Delivery
  42. Topical iontophoresis of buflomedil hydrochloride increases drug bioavailability in the mucosa: A targeted approach to treat oral submucous fibrosis
  43. Using ordered mesoporous silica sba-15 to limit cutaneous penetration and transdermal permeation of organic uv filters
  44. Controlled Iontophoretic Delivery in Vitro and in Vivo of ARN14140—A Multitarget Compound for Alzheimer’s Disease
  45. Er:YAG fractional laser ablation for cutaneous co-delivery of pentoxifylline and d-α-tocopherol succinate: A new approach for topical treatment of radiation-induced skin fibrosis
  46. Delivering vismodegib directly to the skin
  47. Drug Transport across Porcine Intestine Using an Ussing Chamber System: Regional Differences and the Effect of P-Glycoprotein and CYP3A4 Activity on Drug Absorption
  48. Fractional laser ablation for the targeted cutaneous delivery of an anti-CD29 monoclonal antibody – OS2966
  49. Self-assembled mPEG-hexPLA polymeric nanocarriers for the targeted cutaneous delivery of imiquimod
  50. Strategies for modifying drug residence time and ocular bioavailability to decrease treatment frequency for back of the eye diseases
  51. Investigation of Different Iontophoretic Currents Profiles for Short-Term Applications in Cosmetics
  52. Controlled non-invasive iontophoretic delivery of triamcinolone acetonide amino acid ester prodrugs into the posterior segment of the eye
  53. Hyaluronic Acid After Subcutaneous Injection—An Objective Assessment
  54. Simultaneous controlled iontophoretic delivery of pramipexole and rasagiline in vitro and in vivo : Transdermal polypharmacy to treat Parkinson’s disease
  55. Hydrogels in three-dimensional dendritic cell (MUTZ-3) culture as a scaffold to mimic human immuno competent subcutaneous tissue
  56. Needle-free cutaneous delivery of living human cells by Er:YAG fractional laser ablation
  57. Development and validation of a fast and sensitive UHPLC-ESI-MS method for the simultaneous quantification of spironolactone and its metabolites in ocular tissues.
  58. Topical Administration of Spironolactone-Loaded Nanomicelles Prevents Glucocorticoid-Induced Delayed Corneal Wound Healing in Rabbits
  59. Selective delivery of adapalene to the human hair follicle under finite dose conditions using polymeric micelle nanocarriers
  60. Short-duration ocular iontophoresis of ionizable aciclovir prodrugs: A new approach to treat herpes simplex infections in the anterior and posterior segments of the eye
  61. Targeted intracorneal delivery—Biodistribution of triamcinolone acetonide following topical iontophoresis of cationic amino acid ester prodrugs
  62. Formulation challenges for 21st century topical and transdermal delivery systems
  63. Cutaneous iontophoresis of μ-conotoxin CnIIIC—A potent NaV1.4 antagonist with analgesic, anaesthetic and myorelaxant properties
  64. Transdermal therapeutic systems for memantine delivery. Comparison of passive and iontophoretic transport
  65. Basic principles and current status of transcorneal and transscleral iontophoresis
  66. Improved topical delivery of tacrolimus: A novel composite hydrogel formulation for the treatment of psoriasis
  67. Erratum to “Topical iontophoretic delivery of ionizable, biolabile aciclovir prodrugs: A rational approach to improve cutaneous bioavailability” [Eur. J. Pharm. Biopharm. 99 (2016) 103–113]
  68. Topical delivery of diclofenac into and across equine skin from a novel liquid diclofenac epolamine formulation
  69. Controlled transdermal iontophoresis for poly-pharmacotherapy: Simultaneous delivery of granisetron, metoclopramide and dexamethasone sodium phosphate in vitro and in vivo
  70. A UHPLC-UV Method to Quantify Skin Deposition and Transdermal Permeation of Tizanidine Hydrochloride
  71. Cutaneous biodistribution of ionizable, biolabile aciclovir prodrugs after short duration topical iontophoresis: Targeted intraepidermal drug delivery
  72. Fractional Laser Ablation for the Cutaneous Delivery of Triamcinolone Acetonide from Cryomilled Polymeric Microparticles: Creating Intraepidermal Drug Depots
  73. Topical iontophoretic delivery of ionizable, biolabile aciclovir prodrugs: A rational approach to improve cutaneous bioavailability
  74. Polymeric Micelles in Dermal and Transdermal Delivery
  75. Synthesis of 3-azabicyclo[3.2.2]nonanes and their antiprotozoal activities
  76. Transdermal patches: history, development and pharmacology
  77. Self-assembled polymeric nanocarriers for the targeted delivery of retinoic acid to the hair follicle
  78. Targeted cutaneous delivery of ciclosporin A using micellar nanocarriers and the possible role of inter-cluster regions as molecular transport pathways
  79. Colloidal Soft Nanocarrier for Transdermal Delivery of Dopamine Agonist: Ex Vivo and In Vivo Evaluation
  80. Polymeric Micelle Nanocarriers for the Cutaneous Delivery of Tacrolimus: A Targeted Approach for the Treatment of Psoriasis
  81. Controlled iontophoretic delivery of pramipexole: Electrotransport kinetics in vitro and in vivo
  82. Understanding the poor iontophoretic transport of lysozyme across the skin: When high charge and high electrophoretic mobility are not enough
  83. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: Demonstrating local enhanced topical drug delivery to muscle
  84. Targeted local simultaneous iontophoresis of chemotherapeutics for topical therapy of head and neck cancers
  85. Next generation intra- and transdermal therapeutic systems: Using non- and minimally-invasive technologies to increase drug delivery into and across the skin
  86. Controlled Iontophoretic Transport of Huperzine A across Skinin Vitroandin Vivo: Effect of Delivery Conditions and Comparison of Pharmacokinetic Models
  87. Controlled intra- and transdermal protein delivery using a minimally invasive Erbium:YAG fractional laser ablation technology
  88. Microstructured bicontinuous phase formulations: their characterization and application in dermal and transdermal drug delivery
  89. Comparative in vitro and in vivo evaluation of lipid based nanocarriers of Huperzine A
  90. Mathematical models to describe iontophoretic transport in vitro and in vivo and the effect of current application on the skin barrier
  91. Turning Theory into Practice: The Development of Modern Transdermal Drug Delivery Systems and Future Trends
  92. Comparison of the cutaneous iontophoretic delivery of rasagiline and selegiline across porcine and human skin in vitro
  93. Transcutaneous vaccination via laser microporation
  94. The Pharmaceutical Biochemistry Group: Where Pharmaceutical Chemistry Meets Biology and Drug Delivery
  95. Cutaneous iontophoretic delivery of CGP69669A, a sialyl Lewisx mimetic, in vitro
  96. Clinical Applications of Transdermal Iontophoresis
  97. Erbium:YAG fractional laser ablation for the percutaneous delivery of intact functional therapeutic antibodies
  98. Development and validation of a HPAE-PAD method for the quantification of CGP69669A, a sialyl Lewisx mimetic, in skin permeation studies
  99. Noninvasive Transdermal Iontophoretic Delivery of Biologically Active Human Basic Fibroblast Growth Factor
  100. Using laser microporation to improve transdermal delivery of diclofenac: Increasing bioavailability and the range of therapeutic applications
  101. Novel micelle formulations to increase cutaneous bioavailability of azole antifungals
  102. Electrically-assisted delivery of an anionic protein across intact skin: Cathodal iontophoresis of biologically active ribonuclease T1
  103. Human growth hormone: New delivery systems, alternative routes of administration, and their pharmacological relevance
  104. Non-invasive iontophoretic delivery of peptides and proteins across the skin
  105. Comparing metoclopramide electrotransport kinetics in vitro and in vivo
  106. Development and validation of a rapid high-performance liquid chromatography method for the quantification of exenatide
  107. Effect of controlled laser microporation on drug transport kinetics into and across the skin
  108. Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6kDa) across intact porcine and human skins
  109. Transdermal iontophoresis of dexamethasone sodium phosphate in vitro and in vivo: Effect of experimental parameters and skin type on drug stability and transport kinetics
  110. Using transdermal iontophoresis to increase granisetron delivery across skin in vitro and in vivo: Effect of experimental conditions and a comparison with other enhancement strategies
  111. Development and validation of an analytical method for the quantification of cytochrome c in skin transport studies
  112. Stability of triptorelin in the presence of dermis and epidermis
  113. Controlled non-invasive transdermal iontophoretic delivery of zolmitriptan hydrochloride in vitro and in vivo
  114. In vitro evaluation of the effect of electrotreatment on skin permeability
  115. Effect of propylene glycol on ibuprofen absorption into human skin in vivo
  116. In Vivo Methods for the Assessment of Topical Drug Bioavailability
  117. In vitro and in vivo evaluation of the transdermal iontophoretic delivery of sumatriptan succinate
  118. Transdermal Delivery of Cytochrome C—A 12.4 kDa Protein—Across Intact Skin by Constant–Current Iontophoresis
  119. Dermatopharmacokinetic Prediction of Topical Drug Bioavailability In Vivo
  120. Ibuprofen Transport into and through Skin from Topical Formulations: In Vitro–In Vivo Comparison
  121. Structure–permeation relationships for the non-invasive transdermal delivery of cationic peptides by iontophoresis
  122. Topical Iontophoresis of Valaciclovir Hydrochloride Improves Cutaneous Aciclovir Delivery
  123. Pig Ear Skin ex Vivo as a Model for in Vivo Dermatopharmacokinetic Studies in Man
  124. New Developments in Topical Antifungal Therapy
  125. Capillary zone electrophoresis for the estimation of transdermal iontophoretic mobility
  126. Effect of amino acid sequence on transdermal iontophoretic peptide delivery
  127. Contributions of electromigration and electroosmosis to peptide iontophoresis across intact and impaired skin
  128. Yannic B. Schuetz, Aarti Naik, Richard H. Guy, Evelyne Vuaridel, Yogeshvar N. Kalia. Transdermal Iontophoretic Delivery of Triptorelin In Vitro. 94:2175-2182, 2005
  129. Transdermal Iontophoretic Delivery of Triptorelin in Vitro
  130. Effect of Charge and Molecular Weight on Transdermal Peptide Delivery by Iontophoresis
  131. Transdermal Iontophoretic Delivery of Vapreotide Acetate AcrossPorcine Skin in Vitro
  132. Skin permeation enhancement by sucrose esters: A pH-dependent phenomenon
  133. Emerging strategies for the transdermal delivery of peptide and protein drugs
  134. Development of an in vitro model for premature neonatal skin: Biophysical characterization using transepidermal water loss
  135. Assessment of Topical Bioavailability in vivo: The Importance of Stratum corneum Thickness
  136. Iontophoretic Transport across the Skin
  137. Enhancement of Topical Delivery from Biodegradable Nanoparticles
  138. Skin penetration and distribution of polymeric nanoparticles
  139. Visualization of skin penetration using confocal laser scanning microscopy
  140. Porcine Ear Skin as a Model for the Assessment of Transdermal Drug Delivery to Premature Neonates
  141. Iontophoretic drug delivery
  142. Non-invasive assessment of the effect of formulation excipients on stratum corneum barrier function in vivo
  143. Ultrasound‐Enhanced Transdermal Transport
  144. Skin Permeability Enhancement by Low Frequency Sonophoresis: Lipid Extraction and Transport Pathways
  145. Frequency and thermal effects on the enhancement of transdermal transport by sonophoresis
  146. Biophysical Study of Porcine Ear Skin In Vitro and Its Comparison to Human Skin In Vivo
  147. Reverse iontophoretic monitoring in premature neonates: feasibility and potential
  148. In vivo assessment of skin electroporation using square wave pulses
  149. Post-iontophoresis recovery of human skin impedance in vivo
  150. Piroxicam delivery into human stratum corneum in vivo: iontophoresis versus passive diffusion
  151. Passive skin penetration enhancement and its quantification in vitro
  152. Stabilization of supersaturated solutions of a lipophilic drug for dermal delivery
  153. Modeling transdermal drug release
  154. Enhanced skin permeation of a lipophilic drug using supersaturated formulations
  155. Non-invasive assessment of the effects of iontophoresis on human skin in-vivo
  156. Effect of ethanol and isopropyl myristate on the availability of topical terbinafine in human stratum corneum, in vivo
  157. In vivo assessment of enhanced topical delivery of terbinafine to human stratum corneum
  158. Factors and strategies for improving buccal absorption of peptides
  159. Recovery of human skin impedance in vivo after lontophoresis: Effect of metal ions
  160. Transdermal drug delivery: overcoming the skin’s barrier function
  161. Iontophoresis: electrorepulsion and electroosmosis
  162. Ion mobility across human stratum corneum in vivo
  163. Development of Skin Barrier Function in Premature Infants
  164. TRANSDERMAL DRUG DELIVERY
  165. Mechanisms of oral permeation enhancement
  166. Transdermal therapy and diagnosis by iontophoresis
  167. Characterization of the permeability barrier of human skin in vivo
  168. Interaction between penetration enhancers and iontophoresis: effect on human skin impedance in vivo
  169. Transdermal delivery of peptides by iontophoresis
  170. Protein-protein recognition mediated by a mini-protein domain: Possible evolutionary significance
  171. Amperometric enzyme electrodes